CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma [Figure presented]

1. Escudier, B.
2. Sharma, P.
3. McDermott, D.F.
4. George, S.
5. Hammers, H.J.
6. Srinivas, S.
7. Tykodi, S.S.
8. Sosman, J.A.
9. Procopio, G.
10. Plimack, E.R.
11. Castellano, D.
12. Gurney, H.
13. Donskov, F.
14. Peltola, K.
15. Wagstaff, J.
16. Gauler, T.C.
17. Ueda, T.
18. Zhao, H.
19. Waxman, I.M.
20. Motzer, R.J.